Compare FPF & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FPF | NEOG |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | 1989 |
| Metric | FPF | NEOG |
|---|---|---|
| Price | $18.67 | $7.29 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.83 |
| AVG Volume (30 Days) | 186.7K | ★ 3.6M |
| Earning Date | 01-01-0001 | 01-08-2026 |
| Dividend Yield | ★ 8.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $886,886,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.91 | $3.87 |
| 52 Week High | $18.09 | $13.41 |
| Indicator | FPF | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 51.34 | 63.10 |
| Support Level | $18.60 | $6.89 |
| Resistance Level | $18.75 | $7.51 |
| Average True Range (ATR) | 0.13 | 0.25 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 59.09 | 66.36 |
First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.